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Summary
The course of development of hypocortisolism was studied in 20 patients with autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy (APECED) for 1.3-9.3 years during which time the patients underwent at least three 2-h ACTH tests (2hAT). A slow progression of the disease was evident and could be staged. The earliest indicators of incipient failure were subnormality of the 2-h corfiisol level alone or with subnormality of Autoimmune adrenalitis is a major cause of Addison's disease. In patients with polyendocrine deficiency diseases and their siblings, frequent testing of cortisol reserve is essential for early detection of failure of cortisol secretory capacity. Long lasting ACTH tests are impractical, because they entail hospitalization. Furthermore, such tests may not be sensitive enough to detect incipient failure. To our knowledge, no systematic study has appeared on the progression of hypocortisolism in adrenalitis. Neither have criteria been established for early stages of primary hypocortisolism. Such criteria would be important for the safety of individuals at risk. We have used an ambulatory 2-h ACTH test (2hAT) (1 3) for both detection and follow-up of progression of hypocortisolism in our large series of patients with APECED (18, 23) . The 2hAT was clearly more sensitive than the 4dAT for the detection of incipient failure and even more sensitive than determinations of plasma ACTH. Our experience with these patients calls for a revision of the current diagnostic criteria of Addison's disease.
SUBJECTS AND METHODS
Of a total of 40 patients with APECED managed by us in 1970-1980 (23) , 20 are the subjects of this report (Table I ). All patients included in this study had been followed for at least 1 year and with a minimum of three 2hATs. The median interval between tests was 0.8 (range, 0.1-3.3) years. At the start of the follow-up none of the 20 patients was substituted for cortisol and 17 of them had normal adrenocortical function. The diagnosis of APECED was based on the presence of at least two of the following features (or one if a sib had at least two): mucocutaneous candidosis, hypoparathyroidism, hypoadrenocorticism, and ectodermal dystrophy (19, 23) (enamel hypoplasia, onychia punctata). Fourteen of the patients had circulating adrenocortical antibodies. A group of twenty-five children with hypopituitarism including ACTH deficiency were also given a total of 34 2hATs to allow comparison of the results during primary and secondary hypocortisolism. The diagnosis of ACTH deficiency was based on subnormal plasma cortisol response to at least two insulin tests. Most patients also had metyrapone tests, always with a subnormal response. Of the hypopituitary patients, 18 had a hypothalamic tumor, four had been born in breech presentation, one had sequelae of subdural effusion, and two cases were idiopathic.
Cortisol substitution was given as oral cortisol, 7.5-10 mg daily divided in three doses. This substitution was stopped on the day preceding the test and resumed upon completion of the test. Adequate substitution therapy was given for any associated endocrine deficiencies. Aldosterone deficiency was substituted for by 9 a-fluorocortisol, 0.025-0.1 mg daily, in salt-losing patients. The development of mineralocorticoid deficiency will be the subject of another report. Informed consent was obtained before testing the patients.
The 2hAT (13) . the insulin test (14) , and the vasopressin test (1 5) were performed as previously described. For the 4dAT, the patient was hospitalized in order to collect four consecutive 24-h urines for determination of 17-OGS. On days 2, 3, and 4, Zn ACTH,_,, (S-Cortrophin depot, Organon, Netherlands) 1.0 mg/ 1.73 m' was given intramuscularly at 8 a.m. An increment of 35% from the basal 17-OGS indicated a significant response (1 2).
A 2hAT performed on the morning after the 4dAT is called a primed 2hAT. The result of this test was compared with the result of a 2hAT given on the morning before a 4dAT.
Laboratory methods. Plasma 1 I-hydroxycorticoids (hereafter referred to as a cortisol) were determined by a two-point fluorometry method (1 3) with a between-assay coefficient of variation of 4 . 4 % for levels between 15-72 ~gJdl(0.47-2.0 pM). The precision of the method was strictly controlled and the method was unchanged during the period of this study. Its accuracy was evaluated by parallel determination of cortisol with a specific RIA in 34 samples (ranges, 5.4-47 pg/dl by RIA). The correlation was high ( r = 0.96) with linear regression: ~0 r t i s 0 1~~~ = 0.75 cortisolFl + 5.7 pg/dl. Urinary 17-OGS were determined by colorimetry (30) , and reported as mg . m-' . day-'. Plasma ACTH was assayed with a radioimmunoassay kit (Sorin, Biomedica, 13040 Saluggia, Vercelli, Italy). Blood samples were chilled on ice water, and plasma was separated without delay. N-methylmaleinimide was added to an 1 mM concentration, and the mixture was stored at -18°C until assayed for ACTH. The limit of sensitivity was 10 nglliter, and basal levels of >I00 ng/liter were considered elevated. For anti-adrenocortical antibodies (hereafter referred to as antibodies), sera were tested by an indirect imunofluorescence method (1 1).
Statistical anulvsis. Means, S.D.s, and S.E.M.s of endocrine values were calculated from log transformed data; hence, all means are geometric, and S.E.M.s are given as percentages (28) . Normal response criteria for the 2hAT were based on results for 30 healthy children aged 2.8-18.4 years. Because both the 2-h plasma cortisol levels and the 2-h increments showed a strong inter-individual dependence on the basal level, a normal result is most accurately defined by an area formed on a plot of 2-h level verslls basal level by the 95% confidence limits for the estimation of 2-h levels for given basal levels, and by the 95% confidence limits for the basal level (7-36 pgJdl; 0.19-1 .OO pM) (13) . An increment of ~3 . 0 S.D. of the method variability (3 S.D. = 3.0 pgJdl; 0.08 pM) was regarded as significant. The 95% confidence ranges of the results for the reference populations were used as reference ranges for the other tests. For the 4dAT and the primed 2hAT the reference populations consisted of patients who had normal results in the 2hAT. Table 2 and Fig. 1) . Of the 17 patients initially in stage N, four were still in that stage at the end of the study. None of these four patients had antibodies. In Table 2 . Table I. 16 patients, 13 with a normal and three with a subnormal initial result, the response had deteriorated.
RESULTS
Individual follow-up by 2hAT (
Between two consecutive tests there was no change of stage in 69 instances. A "deterioration" had occurred in 35 pairs and an "improvement" in nine pairs.
The first subnormal stage observed after stage N was stage sL in I I patients, stage sLI in eight patients and stage sLaI in one patient (after an interval of 1.6 years).
Subnormal basal levels were observed in only three out of 20 patients in stage sLaI with advanced disease, but in 1 1 out of 15 patients in stage R. After a result from stage-sL, the next result was of the same stage three times, and of a poorer stage four times, but normal four times. After a stage-sLI result the next result was of the same stage three times, of a poorer stage eight times, but of a better stage twice, there being a normal finding once. Only after stage sLaI had shown up in one result were subsequent findings always abnormal, even though a significant increment appeared three times.
The mean interval from the last stage-N result was, to stage sL Table 1 ). The ranges were calculated from the findings in stage-N patients: therefore, for the 2hAT they differ from the ranges of healthy children.
1-80 pg/dl (0.03-2.2 pM). Of five tests in stage-sL or sLI patients all gave normal responses according to the criteria for both the 2hAT and primed 2hAT (Fig. 2) . Of the five stage sLaI patients, in contrast, none gave a normal response; however, a significant increment now appeared in three. In six tests on stage-R patients, four showed no change from the basal 2hAT; in one test an increase appeared in the "basal" level, and in another the increment disappeared.
4-Dav ACTH test. Nine of the 26 4dATs performed were in stage-N patients (see Fig. 3 for the reference ranges obtained from their values). Six of the tests were in stage-sL or sLI patients; all responses were normal (Fig. 3) . In contrast, all five sLaI patients responded subnormally. All three patients with subnormal basal 17-OGS showed a significant increment in 17-OGS. This appeared during the first day in ACTH in one patient and during the second day in two patients. In all three the value then fell i,? spite of continuing ACTH stimulation. In the six stage-R patients responses were variable. Four of them had a significant increment in 17-OGS, one of them an almost normalized level during the third day on ACTH (Fig. 3) . Plasma ACTH concentrations ( Table 3 and Fig. 4 ). Several patients in stage-N, but with antibodies, had elevated ACTH levels. In contrast, all stage-N patients without antibodies had normal levels. Both the proportion of levels that were elevated and the mean level increased varallel to the stage of failure. The mean level for the stage was nbt significantly elevated until stage sLI. Institution of cortisol replacement therapy led to an expected decrease in the mean ACTH level. Cortisol/ACTH molar ratios ( Tuble 3 and Fig. 4 ). In stage-N patients without antibodies the range of the molar ratios was 25-136 x lo3. In all patients with elevated plasma ACTH levels the ratio was below this range. The proportion of ratios that were subnormal (<20 x lo3) increased and the mean ratio decreased parallel to the stage of failure. Even at stage sL the mean ratio for the stage was significantly below the value of stage-N without antibodies.
Inszilin and vusopressin tests. These tests were given to some of the patients in efforts to study the endogenous ACTH reserve. The plasma cortisol increments found in these tests were similar in magnitude to those induced by exogenous ACTH in the 2hAT (Fig. 5) . Surprisingly, in the vasopressin test significant increments were observed in some stage-sLaI patients. Only in stage R was an ACTH reserve never detectable.
2hAT in h~vpocortisolism: APECED versus hypopituitarism.
Before the start of cortisol substitution in the patients with Table 1. cortisolism. But in patients with subnormal 2-h cortisol levels the presence of a significant, even normal, increment in 2hAT does not exclude primary hypocortisolism or establish secondary hypocortisolism.
The pattern of plots for the patients with increments suggests that for a given basal cortisol level the increment is larger in secondary than in primary hypocortisolism (Fig. 6) . Accordingly, both the incrementlbasal level ratio and the 2-h level/basal level ratio were lower ( P < 0.001) in APECED (0.43 + 14% and 1.50 +_ 5%, respectively) than in hypopituitarism (1.14 + 27%, 2.32 + 13%). Only three of the 27 ratios in patients with APECED were below the hypopituitary range.
During cortisol substitution a different picture emerged (Fig.  6) . Now a significant increment was observed in only one of 16 2hATs in patients with APECED, in contrast to 17 of 2 1 tests in patients with hypopituitarism. A significant increment during cortisol substitution strongly suggests secondary hypocortisolism, but absence of an increment does not exclude secondary or establish primary hypocortisolism.
APECED, a significant increment was observed in only 26 of the 46 2hATs; eight of these increments were normal (Fig. 6) . In the DISCUSSION patients with hypopituitarism, in contrast, all 13 tests showed a
In patients with autoimmune adrenalitis, replacement of corsignificant increment, and seven of the increments were normal. tical cells by fibrous tissue and lymphocytic infiltration of the The absence of an increment strongly suggests primarily hypo-remaining islets of cortical cells eventually lead to primary adrenocortical failure (9) . These patients often have circulating adrenocortical antibodies (3, 9, 20) . We have followed the gradual development of hypocortisolism in a group of patients with the adrenalitis of APECED, a disease progressing to adrenocortical failure in about two-thirds of the patients (23) . During progression of the failure in these patients we frequently observed patterns of response in ACTH tests which were in conflict with the established diagnostic criteria of primary hypocortisolism (1, 8, 16, 19, 3 1; see below) . In this report we suggest new criteria for diagnosing and staging primary hypocortisolism by a 2-h ACTH tests. The evidence needed to characterize the state of the adrenal cortex also includes information about plasma ACTH concentrations and the presence of antibodies.
The diagnosis is currently based on two criteria. First, in response to exogenous ACTH an increment in urinary steroids Table 1 . Stage-N (normal response) was divided according to the absence (N-) or presence (Nf) of antibodies. Symbols: @, ACTH <I00 ng/l liter: A. ACTH >I00 ng/liter. The columns indicate the means and S.E.M.S. Three ACTH levels were >720 ng/liter, but the corresponding ratios were calculated using 720 ng/liter; these ratios are therefore underestimated. and plasma cortisol level should be absent. Even a small slow increase has been accepted as adequate evidence of the secondary nature of the hypocortisolism ( I , % , 16, 19,3 1) . Second, especially when plasma cortisol levels are low, plasma ACTH concentrations should be elevated (2, 24) . We found that, during the development of hypocortisolism, the absence of an ACTH-induced increment in plasma or urinary steroids was a late feature, often preceded by years of slow progressive decline in the other parameters of cortisol secretory capacity. We have defined the criteria for the result of the 2hAT by a novel analysis (13) of the results in healthy children. Basal and 2-h cortisol levels show no intra-individual dependence and are thus independent measures of cortisol secretory capacity. In contrast, the increment is totally dependent on the intra-individual variations in the basal and 2-h levels; hence, the increment should not be taken as the sole parameter of the test result (13) . Surprisingly, we observed subnormal basal cortisol levels in only a few patients with far ., R. 
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I Superscripts (-) and (+) indicate absence and presence of antibodies. For the definition of stages (N, sL, sLI, sLaI, R), see footnote in Table 1 .
Significantly (P < 0.05) different from the value of stage N-.
In three of five samples the ACTH concentration was above the measured range (>720 ng/liter), but was taken as 720 ng/liter in the calculations: therefore. the mean is underestimated and the molar ratio overestimated.
LEISTI ET A L advanced disease, presumably long after total depletion of cortisol reserves. An appropriate staging of the responses was obtained by using two parameters in parallel, the 2-h level and the 2-h increment. Because of the inter-individual dependence of both of these on the basal level, the evaluation is best done on a plot of 2-h level versus basal level (13) . As shown by these criteria, the first stage of failing cortisol secretory capacity was a subnormal 2-h level, alone or with a subnormal increment. The urinary 17-OGS response in the 4dAT remained normal as long as there was a significant increment in the 2hAT. A significant response was maintained longer in the 4dAT than in the 2hAT. The 4dAT was thus clearly not sufficiently sensitive to detect incipient or moderate failure of cortisol secretory capacity.
In accordance with our findings, several groups have observed significant responses in plasma and urinary steroids in patients with primary adrenocortical failure. Progression of the failure has also been demonstrated by some authors. In patients with adrenal remnants after subtotal adrenalectomy, increments in both urinary and plasma steroids were only slightly subnormal after 2-3 days infusion of ACTH ( I 0,26) or in a 60-min ACTH test (10) . A response was also obtained in a patient with adrenal calcification (27) . Six patients with mild Addison's disease showed near-normal increments in urinary steroids after ACTH infusion (7) . A child with Addison's disease responded with a 3-fold increase in urinary 17-hydroxycorticosteroids after 3 days on ACTH gel (5) . Adults with the primary adrenocortical failure of Schmidt's (2 1) and Chiari-Frommel's (25) syndromes showed prompt increases in urinary plasma steroids in ACTH tests. Similar increases have been observed in two patients with adrenoleukodystrophy or adrenomyeloneuropathy (6) children with the "syndrome of familial glucocorticoid insufficiency" (17, 29) . During follow-up several of these patients primary adrenocortical failure clearly advanced to absence of an ACTH-induced response (7, 17, 29) . Clearly, the finding of a significant and even normal steroid increment in an ACTH test is not an acceptable criterion for exclusion of primary adrenocortical failure.
As the failure progressed we found an increasing proportion of elevated plasma ACTH levels. Only in patients in whom the 2hAT no longer induced any increment was the ACTH level constantly elevated. Elevated ACTH levels were invariably associated with a subnormal cortisol/ACTH molar ratio and vice versa except among the cortisol-substituted patients, who had subnormal ratios even when ACTH levels were normal. The molar ratio was no more sensitive than the ACTH level as an indicator of the disease, and usually less sensitive than the 2hAT. A normal plasma ACTH level and a normal cortisol/ACTH ratio definitely do not exclude primary adrenocortical failure.
In some patients in whom 2hAT results were normal, ACTH levels were elevated. These patients had antibodies and their cortisol/ACTH ratios were low, indicating incipient adrenocortical failure. They later developed hypocortisolism. High ACTH levels have been reported previously in a patient whose steroid response to ACTH was only slightly subnormal (21) . We suggest that such patients have a compensatory activation of the hypothalamic-pituitary-adrenocortical axis, a notion that is supported by two lines of evidence. First, a prolonged normalization of the 2hAT was observed in two of our patients with antibodies, both of whom later developed hypocortisolism. Such partial recovery has also been reported in a patient with South American blastomycosis (22) . Second, in patients with incipient or moderate hypocortisolism the results-of primed 2hAT were in the normal range. That these patients still have an endogenous reserve of ACTH is proved by the significant cortisol responses to the insulin and vasopressin tests. In conclusion, staging of failing cortisol secretory capacity cannot be based solely on the responses to the ACTH tests. Long lasting ACTH tests are clearly not sensitive enough for detection of early stages, and a normal response to 2hAT does not exclude a lesion. Determinations of plasma ACTH and adrenal antibodies are also needed.
Differentiaton with ACTH tests between patients with primary and secondary hypocortisolism was possible only in specified situations. First, in patients with no cortisol substitution an absent increment in the 2hAT strongly suggested primary hypocortisolism. Second, in patients on cortisol substitution the presence of an increment strongly suggested secondary hypocortisolism. Because even those patients with advanced hypocortisolism gave normal or only slightly subnormal responses in the 4dAT and the primed 2hAT, long lasting ACTH tests appear clearly inappropriate for the differentiation in all but very advanced cases of hypocortisolism. Furthermore, hypopituitary patients with subnormal plasma cortisol response in insulin test often gave normal response in ACTH tests (4, 13) . The differentiation must be based on the clinical picture, and on other tests of pituitary function. Table 1 .
The pathogenetic role of circulating adrenocortical antibodies is unclear. We tested for antibodies in our patients too infrequently to allow conclusions about their constant association or otherwise with the adrenalitis of APECED. Antibodies were not observed in any of those of our patients who did not develop hypocortisolism. They were present in all patients who, despite normal 2hAT results, had elevated plasma ACTH levels and low cortisol/ACTH ratios, presumably indicating an active adrenal lesion. Testing for the antibodies thus appeared positively and negatively predictive of the development of hypocortisolism. The apparent sequence of development of hypocortisolism in APECED is summarized in Table 4 .
